Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
出版年份 2019 全文链接
标题
Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
作者
关键词
-
出版物
Cells
Volume 8, Issue 9, Pages 957
出版商
MDPI AG
发表日期
2019-08-23
DOI
10.3390/cells8090957
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Inhibition of USP2 eliminates cancer stem cells and enhances TNBC responsiveness to chemotherapy
- (2019) Jiabei He et al. Cell Death & Disease
- MicroRNA-224 Promotes Tumorigenesis through Downregulation of Caspase-9 in Triple-Negative Breast Cancer
- (2019) Li Zhang et al. DISEASE MARKERS
- Towards the first targeted therapy for triple-negative breast cancer: Repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor
- (2019) Kamal Ahmed et al. CANCER LETTERS
- A novel PI3K/mTOR dual inhibitor, CMG002, overcomes the chemoresistance in ovarian cancer
- (2019) Hye Joung Choi et al. GYNECOLOGIC ONCOLOGY
- AL101 mediated tumor inhibition in notch-altered TNBC PDX models.
- (2019) Esther Channah Broner et al. JOURNAL OF CLINICAL ONCOLOGY
- STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
- (2019) Jiang-Jiang Qin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Overexpression of microRNA‑620 facilitates the resistance of triple negative breast cancer cells to gemcitabine treatment by targeting DCTD
- (2019) Chao Wu et al. Experimental and Therapeutic Medicine
- Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer
- (2019) Masahiro Shibata et al. Cancers
- MicroRNA-5195-3p enhances the chemosensitivity of triple-negative breast cancer to paclitaxel by downregulating EIF4A2
- (2019) Mei Liu et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin
- (2019) Honghong Shen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The Hedgehog Signaling Pathway: A Viable Target in Breast Cancer?
- (2019) Priyanka Bhateja et al. Cancers
- Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies
- (2019) Khan et al. Cells
- WNT Signaling in Disease
- (2019) Ng et al. Cells
- TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis
- (2018) Xiaodan Xu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3
- (2018) Xiangdong Bai et al. BIOMEDICINE & PHARMACOTHERAPY
- Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In vitro and in vivo
- (2018) Guan-Nan Zhang et al. CANCER LETTERS
- Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification
- (2018) Isabel Echavarria et al. CLINICAL CANCER RESEARCH
- Advances in the systemic treatment of triple-negative breast cancer
- (2018) J.M. Lebert et al. Current Oncology
- STAT3 as a promising chemoresistance biomarker associated with the CD44 +/high /CD24 -/low /ALDH + BCSCs-like subset of the triple-negative breast cancer (TNBC) cell line
- (2018) Milene Pereira Moreira et al. EXPERIMENTAL CELL RESEARCH
- STAT3: a multifaceted oncoprotein
- (2018) Aleks C. Guanizo et al. GROWTH FACTORS
- Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer
- (2018) Abhishek Gangrade et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066
- (2018) Cong-Cong Cheng et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Interleukin-6 contributes to chemoresistance in MDA-MB-231 cells via targeting HIF-1α
- (2018) Ke Wang et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- MicroRNAs in regulation of triple-negative breast cancer progression
- (2018) Dominika Piasecka et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma
- (2018) Kevin D. Courtney et al. JOURNAL OF CLINICAL ONCOLOGY
- Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells
- (2018) Shaocong Wu et al. Molecular Cancer
- miRNAs as Potential Treatment Targets and Treatment Options in Cancer
- (2018) Nina Petrovic et al. Molecular Diagnosis & Therapy
- Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
- (2018) Andrew Tutt et al. NATURE MEDICINE
- Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer
- (2018) Sherona R. Sirkisoon et al. ONCOGENE
- MCL-1 is a prognostic indicator and drug target in breast cancer
- (2018) Kirsteen J. Campbell et al. Cell Death & Disease
- Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft
- (2018) Santosh K. Bharti et al. Oncotarget
- Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicin
- (2018) Touko Inao et al. Oncotarget
- NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest
- (2018) Giulia Diluvio et al. Oncogenesis
- Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer
- (2018) Naoko Matsuda et al. JAMA Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A novel recombinant human Frizzled-7 protein exhibits anti-tumor activity against triple negative breast cancer via abating Wnt/β-catenin pathway
- (2018) Wei Xie et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant Trial
- (2018) Aditya Bardia et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall survival (OS) update of the double-blind placebo (PBO)-controlled randomized phase 2 LOTUS trial of first-line ipatasertib (IPAT) + paclitaxel (PAC) for locally advanced/metastatic triple-negative breast cancer (mTNBC).
- (2018) Rebecca Dent et al. JOURNAL OF CLINICAL ONCOLOGY
- AZD5363 plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (PAKT): A randomised, double-blind, placebo-controlled, phase II trial.
- (2018) Peter Schmid et al. JOURNAL OF CLINICAL ONCOLOGY
- The inhibitory effects of plumbagin on the NF-қB pathway and CCL2 release in racially different triple-negative breast cancer cells
- (2018) Samia S. Messeha et al. PLoS One
- Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy
- (2018) Fouzia Guestini et al. BREAST CANCER RESEARCH AND TREATMENT
- BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
- (2018) Delphine Merino et al. CANCER CELL
- A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors
- (2018) David C. Smith et al. INVESTIGATIONAL NEW DRUGS
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Signaling pathway inhibitors target breast cancer stem cells in triple-negative breast cancer
- (2018) Wenlong Li et al. ONCOLOGY REPORTS
- Racial Disparity and Triple-Negative Breast Cancer in African-American Women: A Multifaceted Affair between Obesity, Biology, and Socioeconomic Determinants
- (2018) Sumit Siddharth et al. Cancers
- Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer
- (2017) Aeri Kim et al. Journal of Breast Cancer
- Role of Wnt Co-Receptor LRP6 in Triple Negative Breast Cancer Cell Migration and Invasion
- (2017) Jinlu Ma et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Targeting BCRP/ABCG2 by RNA interference enhances the chemotherapy sensitivity of human colon cancer side population cells
- (2017) Jun Hu et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC)
- (2017) Fei Ma et al. MEDICINE
- MicroRNAs in the prognosis of triple-negative breast cancer
- (2017) Lingshuang Lü et al. MEDICINE
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
- (2017) Mark Robson et al. NEW ENGLAND JOURNAL OF MEDICINE
- A microRNA signature associated with pathological complete response to novel neoadjuvant therapy regimen in triple-negative breast cancer
- (2017) Raúl García-Vazquez et al. TUMOR BIOLOGY
- Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells
- (2017) Yoshikazu Koike et al. Breast Cancer
- The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth
- (2017) Hyun Seung Ban et al. Cell Death & Disease
- Co‑activation of Hedgehog and Wnt signaling pathways is associated with poor outcomes in triple negative breast cancer
- (2017) Kimberly Arnold et al. Oncology Letters
- Function of insulin‑like growth factor 1 receptor in cancer resistance to chemotherapy (Review)
- (2017) Jingsheng Yuan et al. Oncology Letters
- CD44+/CD24‑ phenotype predicts a poor prognosis in triple‑negative breast cancer
- (2017) Hui Wang et al. Oncology Letters
- The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis
- (2017) Federica Fusella et al. Nature Communications
- Indomethacin-based stimuli-responsive micelles combined with paclitaxel to overcome multidrug resistance
- (2017) Shuanghu Wang et al. Oncotarget
- Phosphoproteome profiling reveals critical role of JAK-STAT signaling in maintaining chemoresistance in breast cancer
- (2017) Augusto S. Nascimento et al. Oncotarget
- STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer
- (2017) Wei-Ying Kuo et al. Theranostics
- The Wnt signaling pathway in cancer
- (2016) Yann Duchartre et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- miR-302a/b/c/d cooperatively inhibit BCRP expression to increase drug sensitivity in breast cancer cells
- (2016) Yan Wang et al. GYNECOLOGIC ONCOLOGY
- Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6 ) in breast cancer
- (2016) Gabriele Corda et al. JOURNAL OF PATHOLOGY
- Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer
- (2016) S Chouaib et al. ONCOGENE
- Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence
- (2016) Justin M. Balko et al. Science Translational Medicine
- Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancer
- (2016) Min-Sun Jin et al. VIRCHOWS ARCHIV
- Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer
- (2016) Marzia A. Locatelli et al. Oncotarget
- Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer
- (2016) Abderrahim El Guerrab et al. Oncotarget
- Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells
- (2016) Lili He et al. Frontiers in Pharmacology
- Notch3 inhibits epithelial–mesenchymal transition by activating Kibra-mediated Hippo/YAP signaling in breast cancer epithelial cells
- (2016) X Zhang et al. Oncogenesis
- Hypoxia Induced NF-κB
- (2016) Laura D’Ignazio et al. Cells
- Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
- (2016) Brian D. Lehmann et al. PLoS One
- Polymer Nanoparticles Mediated Codelivery of AntimiR-10b and AntimiR-21 for Achieving Triple Negative Breast Cancer Therapy
- (2015) Rammohan Devulapally et al. ACS Nano
- Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy
- (2015) Baek Kim et al. BMC CANCER
- A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic triple negative breast cancer
- (2015) S Cowherd et al. CANCER BIOLOGY & THERAPY
- Wnt/ -Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells
- (2015) G.-B. Jang et al. CANCER RESEARCH
- A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer
- (2015) G. Giaccone et al. EUROPEAN JOURNAL OF CANCER
- A Time to Kill: Targeting Apoptosis in Cancer
- (2015) Jean Koff et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer
- (2015) Mitesh J. Borad et al. JOURNAL OF CLINICAL ONCOLOGY
- FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance
- (2015) David Westover et al. Molecular Cancer
- Targeting the TGFβ pathway for cancer therapy
- (2015) Cindy Neuzillet et al. PHARMACOLOGY & THERAPEUTICS
- Hypoxia-inducible factor-1α induces multidrug resistance protein in colon cancer
- (2015) Yingqian Lv et al. OncoTargets and Therapy
- Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple-negative breast cancer SUM 159 cells
- (2015) MANUELA LABBOZZETTA et al. Oncology Letters
- Selective killing of breast cancer cells expressing activated CD44 using CD44 ligand-coated nanoparticles in vitro and in vivo
- (2015) Cuixia Yang et al. Oncotarget
- FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast Cancer
- (2015) Bingchen Han et al. Cell Reports
- Role of IGF1R in Breast Cancer Subtypes, Stemness, and Lineage Differentiation
- (2015) Susan M. Farabaugh et al. Frontiers in Endocrinology
- The Emerging Regulation of VEGFR-2 in Triple-Negative Breast Cancer
- (2015) Xiaoxia Zhu et al. Frontiers in Endocrinology
- β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells
- (2015) Jinhua Xu et al. PLoS One
- Upregulation of IGF-1R Expression during Neoadjuvant Therapy Predicts Poor Outcome in Breast Cancer Patients
- (2015) Sandra Heskamp et al. PLoS One
- Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact
- (2014) J. M. Nabholtz et al. ANNALS OF ONCOLOGY
- Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study
- (2014) M. V. Dieci et al. ANNALS OF ONCOLOGY
- Enriched CD44+/CD24− population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC)
- (2014) Fei Ma et al. CANCER LETTERS
- Getting TRAIL back on track for cancer therapy
- (2014) J Lemke et al. CELL DEATH AND DIFFERENTIATION
- Hallmarks of triple negative breast cancer emerging at last?
- (2014) Rosa Bernardi et al. CELL RESEARCH
- Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
- (2014) M. D. Burstein et al. CLINICAL CANCER RESEARCH
- The EGFR Pathway Regulates BCRP Expression in NSCLC Cells: Role of Erlotinib
- (2014) Letizia Porcelli et al. CURRENT DRUG TARGETS
- High EGFR gene copy number predicts poor outcome in triple-negative breast cancer
- (2014) Heae Surng Park et al. MODERN PATHOLOGY
- Taxane-induced hedgehog signaling is linked to expansion of breast cancer stem-like populations after chemotherapy
- (2014) Jennifer Sims-Mourtada et al. MOLECULAR CARCINOGENESIS
- XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway
- (2014) Xi Chen et al. NATURE
- Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
- (2014) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- STAT3 Signaling Is Activated Preferentially in Tumor-Initiating Cells in Claudin-Low Models of Human Breast Cancer
- (2014) Wei Wei et al. STEM CELLS
- Gli-1 is crucial for hypoxia-induced epithelial-mesenchymal transition and invasion of breast cancer
- (2014) Jianjun Lei et al. TUMOR BIOLOGY
- Wnt signaling in triple negative breast cancer is associated with metastasis
- (2013) Nandini Dey et al. BMC CANCER
- High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival
- (2013) Akimitsu Yamada et al. BREAST CANCER RESEARCH AND TREATMENT
- Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8
- (2013) Z. C. Hartman et al. CANCER RESEARCH
- Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
- (2013) A. F. Schott et al. CLINICAL CANCER RESEARCH
- Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast
- (2013) Alessandra Rustighi et al. EMBO Molecular Medicine
- Nonclassical Activation of Hedgehog Signaling Enhances Multidrug Resistance and Makes Cancer Cells Refractory to Smoothened-targeting Hedgehog Inhibition
- (2013) Shamik Das et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
- (2013) Neil E. Bhola et al. JOURNAL OF CLINICAL INVESTIGATION
- Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer
- (2013) José Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
- Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer
- (2013) Mevlude Inanc et al. MEDICAL ONCOLOGY
- Tumor-Initiating Cells and FZD8 Play a Major Role in Drug Resistance in Triple-Negative Breast Cancer
- (2013) S. Yin et al. MOLECULAR CANCER THERAPEUTICS
- Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer
- (2013) A. Prat et al. ONCOLOGIST
- Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR
- (2013) D. A. Ferraro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients
- (2013) Minghui Zhang et al. Targeted Oncology
- Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets
- (2013) J. M. Balko et al. Cancer Discovery
- First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
- (2013) Josep Tabernero et al. Cancer Discovery
- Tumour Hypoxia Affects the Responsiveness of Cancer Cells to Chemotherapy and Promotes Cancer Progression
- (2012) Jean-Philippe Cosse et al. Anti-Cancer Agents in Medicinal Chemistry
- Breast cancer, side population cells and ABCG2 expression
- (2012) K.M. Britton et al. CANCER LETTERS
- Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells
- (2012) Ming Qiu et al. CANCER LETTERS
- Molecular Pathways: Targeting the TGF- Pathway for Cancer Therapy
- (2012) A. L. Smith et al. CLINICAL CANCER RESEARCH
- Hypoxia-inducible factor-2a is associated with ABCG2 expression, histology-grade and Ki67 expression in breast invasive ductal carcinoma
- (2012) Lei Xiang et al. Diagnostic Pathology
- Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway
- (2012) HONG PAN et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer
- (2012) Lisa A. Carey et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting Inhibitors of Apoptosis Proteins (IAPs) For New Breast Cancer Therapeutics
- (2012) Shaomeng Wang et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Insulin-like Growth Factor Receptor Inhibitors: Baby or the Bathwater?
- (2012) D. Yee JNCI-Journal of the National Cancer Institute
- SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors
- (2012) Marco Montagner et al. NATURE
- Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy
- (2011) Sibylle Loibl et al. BREAST CANCER RESEARCH AND TREATMENT
- An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer
- (2011) H E Lee et al. BRITISH JOURNAL OF CANCER
- TGF /TNF -Mediated Epithelial-Mesenchymal Transition Generates Breast Cancer Stem Cells with a Claudin-Low Phenotype
- (2011) M. K. Asiedu et al. CANCER RESEARCH
- Hedgehog Overexpression Is Associated with Stromal Interactions and Predicts for Poor Outcome in Breast Cancer
- (2011) S. A. O'Toole et al. CANCER RESEARCH
- Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERα negative breast cancer cell lines
- (2011) Yeon-Jin Kwon et al. CLINICAL & EXPERIMENTAL METASTASIS
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Latent TGF-β structure and activation
- (2011) Minlong Shi et al. NATURE
- Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
- (2011) Ingrid E. Wertz et al. NATURE
- Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61
- (2011) L G Harris et al. ONCOGENE
- Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor
- (2010) H. Harrison et al. CANCER RESEARCH
- High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti-IGF-IR Therapy
- (2010) B. C. Litzenburger et al. CLINICAL CANCER RESEARCH
- Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer
- (2010) S. Y. Park et al. CLINICAL CANCER RESEARCH
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
- (2010) U. Bogdahn et al. NEURO-ONCOLOGY
- The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy
- (2009) E Y Tan et al. BRITISH JOURNAL OF CANCER
- Pharmacogenetics of Membrane Transporters: An Update on Current Approaches
- (2009) Tristan M. Sissung et al. MOLECULAR BIOTECHNOLOGY
- A Novel Two Mode-Acting Inhibitor of ABCG2-Mediated Multidrug Transport and Resistance in Cancer Chemotherapy
- (2009) Hui Peng et al. PLoS One
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors
- (2008) L S Steelman et al. ONCOGENE
- Hypoxia and Aggressive Tumor Phenotype: Implications for Therapy and Prognosis
- (2008) P. Vaupel ONCOLOGIST
- ABC multidrug transporters: structure, function and role in chemoresistance
- (2007) Frances J Sharom PHARMACOGENOMICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started